Leadless pacemaker implantation in a patient with a fully magnetically levitated left ventricular assist device

Yuichiro Miyazaki; Mitsuru Wada; Koichi Yoshitake; Hiroki Mochizuki; Kohei Ishibashi; Takashi Noda; Norihide Fukushima; Kengo Kusano

doi:10.1111/pace.14182

Leadless pacemaker implantation in a patient with a fully magnetically levitated left ventricular assist device

Yuichiro Miyazaki, Mitsuru Wada, Koichi Yoshitake, Hiroki Mochizuki, Kohei Ishibashi, Takashi Noda, Norihide Fukushima, Kengo Kusano

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Left ventricular assist device (LVAD) therapy is increasingly used in patients with end-stage heart failure. However, LVADs are associated with challenges, especially in the presence of a cardiac implantable electronic device. Although a leadless pacemaker (PM), the Micra™ Transcatheter Pacing System, can be used with LVADs, data regarding HeartMate 3™ LVAD are limited. In this report, we present a patient with a HeartMate 3™ LVAD who underwent successful leadless PM implantation after the removal of an infected cardiac resynchronization therapy defibrillator.

Original language	English
Pages (from-to)	1126-1129
Number of pages	4
Journal	PACE - Pacing and Clinical Electrophysiology
Volume	44
Issue number	6
DOIs	https://doi.org/10.1111/pace.14182
Publication status	Published - 2021 Jun
Externally published	Yes

Keywords

electromagnetic interference
HeartMate 3(
Leadless pacemaker
left ventricular assist device
Micra Transcatheter Pacing System

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1111/pace.14182

Cite this

@article{6338ba1e69584b178d6336168e573ebe,

title = "Leadless pacemaker implantation in a patient with a fully magnetically levitated left ventricular assist device",

abstract = "Left ventricular assist device (LVAD) therapy is increasingly used in patients with end-stage heart failure. However, LVADs are associated with challenges, especially in the presence of a cardiac implantable electronic device. Although a leadless pacemaker (PM), the Micra{\texttrademark} Transcatheter Pacing System, can be used with LVADs, data regarding HeartMate 3{\texttrademark} LVAD are limited. In this report, we present a patient with a HeartMate 3{\texttrademark} LVAD who underwent successful leadless PM implantation after the removal of an infected cardiac resynchronization therapy defibrillator.",

keywords = "electromagnetic interference, HeartMate 3(, Leadless pacemaker, left ventricular assist device, Micra Transcatheter Pacing System",

author = "Yuichiro Miyazaki and Mitsuru Wada and Koichi Yoshitake and Hiroki Mochizuki and Kohei Ishibashi and Takashi Noda and Norihide Fukushima and Kengo Kusano",

note = "Publisher Copyright: {\textcopyright} 2021 Wiley Periodicals LLC",

year = "2021",

month = jun,

doi = "10.1111/pace.14182",

language = "English",

volume = "44",

pages = "1126--1129",

journal = "PACE - Pacing and Clinical Electrophysiology",

issn = "0147-8389",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Leadless pacemaker implantation in a patient with a fully magnetically levitated left ventricular assist device

AU - Miyazaki, Yuichiro

AU - Wada, Mitsuru

AU - Yoshitake, Koichi

AU - Mochizuki, Hiroki

AU - Ishibashi, Kohei

AU - Noda, Takashi

AU - Fukushima, Norihide

AU - Kusano, Kengo

PY - 2021/6

Y1 - 2021/6

N2 - Left ventricular assist device (LVAD) therapy is increasingly used in patients with end-stage heart failure. However, LVADs are associated with challenges, especially in the presence of a cardiac implantable electronic device. Although a leadless pacemaker (PM), the Micra™ Transcatheter Pacing System, can be used with LVADs, data regarding HeartMate 3™ LVAD are limited. In this report, we present a patient with a HeartMate 3™ LVAD who underwent successful leadless PM implantation after the removal of an infected cardiac resynchronization therapy defibrillator.

AB - Left ventricular assist device (LVAD) therapy is increasingly used in patients with end-stage heart failure. However, LVADs are associated with challenges, especially in the presence of a cardiac implantable electronic device. Although a leadless pacemaker (PM), the Micra™ Transcatheter Pacing System, can be used with LVADs, data regarding HeartMate 3™ LVAD are limited. In this report, we present a patient with a HeartMate 3™ LVAD who underwent successful leadless PM implantation after the removal of an infected cardiac resynchronization therapy defibrillator.

KW - electromagnetic interference

KW - HeartMate 3(

KW - Leadless pacemaker

KW - left ventricular assist device

KW - Micra Transcatheter Pacing System

UR - http://www.scopus.com/inward/record.url?scp=85102295519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102295519&partnerID=8YFLogxK

U2 - 10.1111/pace.14182

DO - 10.1111/pace.14182

M3 - Article

C2 - 33521993

AN - SCOPUS:85102295519

SN - 0147-8389

VL - 44

SP - 1126

EP - 1129

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

IS - 6

ER -

Leadless pacemaker implantation in a patient with a fully magnetically levitated left ventricular assist device

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this